These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 85487)

  • 1. Specific cellular immune responses in patients with malignant gliomas.
    Sheikh KM; Apuzzo ML; Weiss MH
    Cancer Res; 1979 May; 39(5):1733-8. PubMed ID: 85487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative cell-mediated immune status of patients with malignant glial tumors.
    Sheikh KM; Apuzzo ML; Weiss MH
    Neurol Res; 1979; 1(2):133-45. PubMed ID: 233266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpesvirus type 1 serum antibodies and brain tumors in humans.
    Hadfield MG; Murray BK; Thomson TA; Young HF
    Clin Neuropathol; 1984; 3(2):68-71. PubMed ID: 6325061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular immunity in human brain tumours (author's transl)].
    Böker DK
    Neurochirurgia (Stuttg); 1980 Nov; 23(6):229-34. PubMed ID: 7442895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
    Rudczynski AB; Dyer CA; Mortensen RF
    Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heterogenous immune reactivity in brain tumors: results of cellular immunity in relation to brain tissue antigens].
    Meyer-Rienecker HJ; Jenssen HL; Mix E
    Fortschr Neurol Psychiatr; 1985 Oct; 53(10):363-9. PubMed ID: 2415433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
    Levy NL
    J Immunol; 1978 Sep; 121(3):903-15. PubMed ID: 211167
    [No Abstract]   [Full Text] [Related]  

  • 9. The need to establish whether the leukocyte adherence inhibition test is a reliable assay of tumor immunity in humans.
    Hellström KE; Hellström I
    Cancer Res; 1979 Feb; 39(2 Pt 2):649-50. PubMed ID: 83919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro demonstration of cell-mediated immunity to human brain tumors.
    Levy NL; Mahaley MS; Day ED
    Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410
    [No Abstract]   [Full Text] [Related]  

  • 11. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
    Thomson DM
    Cancer Res; 1979 Feb; 39(2 Pt 2):627-9. PubMed ID: 83917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
    Holán V; Síbl O; Hasek M
    Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autosensitization of neurosurgical cases by normal brain tissue antigens (author's transl)].
    Oda Y; Tokuriki Y; Takeuchi J; Handa H
    No Shinkei Geka; 1979 Oct; 7(10):953-9. PubMed ID: 392328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogenic lectin receptors of nervous system tumors. Study of gliomas, neural crest tumors, and meningiomas in vitro using phytohemagglutinin and concanavalin A.
    Liwnicz BH
    J Neuropathol Exp Neurol; 1982 May; 41(3):281-97. PubMed ID: 6281395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor immunology: a neurosurgical perspective. II. The immunology of glial neoplasms.
    Apuzzo ML
    Bull Los Angeles Neurol Soc; 1976 Oct; 41(4):176-83. PubMed ID: 74264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
    Grosser N; Thomson DM
    Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum acute-phase proteins and immunoglobulins in patients with gliomas.
    Weiss JF; Morantz RA; Bradley WP; Chretien PB
    Cancer Res; 1979 Feb; 39(2 Pt 1):542-4. PubMed ID: 83910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of cell-mediated antitumor immunity in rats bearing syngeneic tumors by the leukocyte adherence inhibition test.
    Kalafut F; Hung PM; Novotná L; Grófová M
    Neoplasma; 1978; 25(5):569-75. PubMed ID: 310970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The features of the brain immune system in brain neoplasms].
    Starchenko AA; Khil'ko VA; Komarets SA; Shulev IuA; Ivanteeva EP; Bikmullin VN; Prilukova TI
    Zh Vopr Neirokhir Im N N Burdenko; 2002; (4):22-6; discussion 26-7. PubMed ID: 12608143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.